Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

California is not one of those states. Newsom in October rejected a $35 monthly insulin copay cap. In his veto message, he cited the state’s $100 million investment in insulin production as an example ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

Simply sign up to the Pharmaceuticals sector myFT Digest ... “There’s a lot of good science that got started in the 2021-22 period and is struggling to get funded, so hopefully at JPMorgan ...

Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...

A longtime pharmaceutical executive laments the woeful state of the industry and calls for new leadership to win back public ...

including the merger of its pharmaceuticals and oncology businesses into a single unit with separate US and international commercial operations, and a cost-cutting drive that aims to save $1.5 ...

And among already public U.S. biotechs, many saw their stock prices slide as pharmaceutical companies looked elsewhere ... Since hitting a record high in 2021, the number of biotech IPOs per year has ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

As the major players in the hyper-scale shift of injectable drugs that treat obesity, investors may be pondering which pharmaceutical giant is the better investment at the moment. Eli Lilly’s ...